Summary
The global Peptide Based Infection Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Peptide therapies are proteins that are administered into the body in order to treat certain diseases. Peptides can act as hormones, cytokines, neurotransmitters, ions channel regulators, growth promoters, and anti-bodies; in fact, they play a variety of roles in all cells of the human body. Normally, amino acids from the protein of a cell are mixed with another peptide in order to synthesize a complete protein molecule. In peptide therapies, the peptide molecules are formulated with a specific target and are then combined with carrier substances in order to increase its strength. This strength increases while the amount of time that the peptide remains in the body is lengthened.
Market Dynamics
Adoption of artificial intelligence for R&D in peptide therapeutics is expected to propel growth of the peptide-based infection therapeutics market over the forecast period. For instance, in August 2021, Cerebras Systems, a provider of artificial intelligence (AI) compute, partnered with Peptilogics, a biotechnology platform company, for R&D in peptide therapeutics through AI.
R&D in peptide therapeutics is expected to offer lucrative growth opportunities for players in the peptide-based infection therapeutics market. For instance, in August 2021, NYU Tandon published a paper describing Amilo 5-MER, a novel peptide with broad therapeutic potential to combat chronic inflammation in multiple diseases. Moreover, increasing funding for R&D in peptide therapeutics is also expected to offer lucrative growth opportunities for players in the peptide-based infection therapeutics market For instance, in August 2021, Laronde, a provider of Endless RNA (eRNA), raised US$ 440 Million in a Series B Financing to advance the development of its eRNA platform and a broad pipeline of programs across a number of therapeutic categories.
Key Takeaways
- R&D in peptide therapeutics is expected to offer lucrative growth opportunities for players in the peptide-based infection therapeutics market. For instance, in August 2021, Ferring Pharmaceuticals adopted Genedata Bioprocess from Genedata, a provider of enterprise software solutions for biopharmaceutical R&D, to support end-to-end protein and antibody development processes in their newly formed Biologics Technologies and Development R&D units.
- Major players operating in the peptide-based infection therapeutics market are focused on R&D to expand their product portfolio. For instance, in August 2021, NovaBiotics Ltd, a privately held clinical stage company, presented its novel peptide drug candidates at the Peptide Therapeutics Forum 2021.
- Major players operating in the peptide-based infection therapeutics market include, Gilead Sciences, Johnson & Johnson, Vertex Pharmaceuticals, Mitsubishi Tanabe Pharma, and Medivir
The Peptide Based Infection Therapeutics Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Peptide Based Infection Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Gilead Sciences
- Johnson & Johnson (Janssen)
- Vertex Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Medivir
- ...
By the Product Type, the market is primarily segmented into:
- Telaprevir
- Sofosbuvir
- Others
By Applications, the market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Peptide Based Infection Therapeutics Market Report:
- To assess the size of the market by value and volume
- Analyze the Peptide Based Infection Therapeutics Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Peptide Based Infection Therapeutics Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Peptide Based Infection Therapeutics Market
The Peptide Based Infection Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Peptide Based Infection Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
Peptide Based Infection Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Peptide Based Infection Therapeutics
1.1 Peptide Based Infection Therapeutics Market Overview
1.1.1 Peptide Based Infection Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Peptide Based Infection Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Peptide Based Infection Therapeutics Market by Type
1.3.1 Global Peptide Based Infection Therapeutics Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Peptide Based Infection Therapeutics Revenue Market Share by Type in 2018
1.3.3 Telaprevir
1.3.4 Sofosbuvir
1.3.5 Others
1.4 Peptide Based Infection Therapeutics Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global Peptide Based Infection Therapeutics Competition Analysis by Players
2.1 Global Peptide Based Infection Therapeutics Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans
3 Company (Top Players) Profiles and Key Data
3.1 Gilead Sciences
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Peptide Based Infection Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Johnson & Johnson (Janssen)
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Peptide Based Infection Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Vertex Pharmaceuticals
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Peptide Based Infection Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Mitsubishi Tanabe Pharma
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Peptide Based Infection Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Medivir
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Peptide Based Infection Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
...
4 Global Peptide Based Infection Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Peptide Based Infection Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Peptide Based Infection Therapeutics in Future
4.4 Top Consumer/End Users of Peptide Based Infection Therapeutics
5 North America Peptide Based Infection Therapeutics Development Status and Outlook
5.1 North America Peptide Based Infection Therapeutics Market Size (2014-2019)
5.2 North America Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
5.3 North America Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
6 Europe Peptide Based Infection Therapeutics Development Status and Outlook
6.1 Europe Peptide Based Infection Therapeutics Market Size (2014-2019)
6.2 Europe Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
6.3 Europe Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
7 China Peptide Based Infection Therapeutics Development Status and Outlook
7.1 China Peptide Based Infection Therapeutics Market Size (2014-2019)
7.2 China Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
7.3 China Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
8 Rest of Asia Pacific Peptide Based Infection Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
9 Central & South America Peptide Based Infection Therapeutics Development Status and Outlook
9.1 Central & South America Peptide Based Infection Therapeutics Market Size (2014-2019)
9.2 Central & South America Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
10 Middle East & Africa Peptide Based Infection Therapeutics Development Status and Outlook
10.1 Middle East & Africa Peptide Based Infection Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Peptide Based Infection Therapeutics Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Peptide Based Infection Therapeutics Market Size by Application (2014-2019)
11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Peptide Based Infection Therapeutics Market Size by Regions (2019-2025)
11.1.1 North America Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Peptide Based Infection Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Peptide Based Infection Therapeutics Market Size by Application (2019-2025)
11.3 The Market Drivers in Future
12 Peptide Based Infection Therapeutics Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Table
List of Tables and Figures
Figure Global Peptide Based Infection Therapeutics Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Peptide Based Infection Therapeutics Market Share by Regions (2014-2019)
Figure North America Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Peptide Based Infection Therapeutics Market Share by Type in 2018 & 2025
Figure Telaprevir Market Size (Million USD) and Growth Rate (2014-2019)
Figure Sofosbuvir Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Peptide Based Infection Therapeutics Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Peptide Based Infection Therapeutics Market Share by Application in 2018 & 2025
Figure Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2014-2019)
Figure Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate in Retail Pharmacies (2014-2019)
Figure Peptide Based Infection Therapeutics Market Size (Million USD) and Growth Rate in Online Pharmacies (2014-2019)
Table Global Peptide Based Infection Therapeutics Revenue (Million US$) by Players (2014-2019)
Table Global Peptide Based Infection Therapeutics Revenue Market Share by Players (2014-2019)
Eigure Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table Global Peptide Based Infection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Peptide Based Infection Therapeutics Market Share in 2018
Figure Global Top 10 Players Peptide Based Infection Therapeutics Market Share in 2018
Table Peptide Based Infection Therapeutics Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Gilead Sciences Basic Information List
Table Gilead Sciences Description and Business Overview
Table Gilead Sciences Peptide Based Infection Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Infection Therapeutics Business of Gilead Sciences (2014-2019)
Table Gilead Sciences Peptide Based Infection Therapeutics Recent Developments
Table Johnson & Johnson (Janssen) Basic Information List
Table Johnson & Johnson (Janssen) Description and Business Overview
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Infection Therapeutics Business of Johnson & Johnson (Janssen) (2014-2019)
Table Johnson & Johnson (Janssen) Peptide Based Infection Therapeutics Recent Developments
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Description and Business Overview
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Infection Therapeutics Business of Vertex Pharmaceuticals (2014-2019)
Table Vertex Pharmaceuticals Peptide Based Infection Therapeutics Recent Developments
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Description and Business Overview
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Infection Therapeutics Business of Mitsubishi Tanabe Pharma (2014-2019)
Table Mitsubishi Tanabe Pharma Peptide Based Infection Therapeutics Recent Developments
Table Medivir Basic Information List
Table Medivir Description and Business Overview
Table Medivir Peptide Based Infection Therapeutics Products, Services and Solutions
Table Revenue (Million US$) in Peptide Based Infection Therapeutics Business of Medivir (2014-2019)
Table Medivir Peptide Based Infection Therapeutics Recent Developments
Table Global Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Figure Global Peptide Based Infection Therapeutics Revenue Market Share by Type in 2018
Table Global Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Global Peptide Based Infection Therapeutics Revenue Market by Application in 2018
Table Top Consumer/End Users of Peptide Based Infection Therapeutics
Figure North America Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure North America Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table North America Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure North America Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure North America Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure Europe Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Europe Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table Europe Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Europe Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure Europe Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure China Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table China Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure China Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table China Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure China Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure China Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure Central & South America Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table Central & South America Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure Middle East & Africa Peptide Based Infection Therapeutics Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Peptide Based Infection Therapeutics Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Peptide Based Infection Therapeutics Market Size Share by Players in 2018
Table Middle East & Africa Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Peptide Based Infection Therapeutics Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Peptide Based Infection Therapeutics Market Size Share by Application in 2018
Figure Global Peptide Based Infection Therapeutics Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Peptide Based Infection Therapeutics Market Size by Regions (2019-2025) (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size Share by Regions in 2025
Figure North America Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Peptide Based Infection Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Peptide Based Infection Therapeutics Market Size by Application (2019-2025) (Million USD)
Figure Global Peptide Based Infection Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size by Application in 2025
Table Global Peptide Based Infection Therapeutics Market Size by Type (2019-2025) (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size by Type (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Request Discount 
Inquire Before Buy
